Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
In a letter, 44 firms, including Allianz, Handelsbanken, Aberdeen Investment and Aegon NV, said a law would give investors more confidence to make long-term decisions on environmentally responsible projects. The move showcases investors' increased focus on climate change, both as a risk and an opportunity. Quoting the "catastrophic" impact of ignoring the issue, the group said uncontrolled climate change could cost the global economy $23 trillion. "Conversely, greater action on climate change could deliver $26 trillion in global economic benefit by 2030," the letter, released Friday, said. Most of the 28 EU member states have signed up to an EU-wide pledge to be climate neutral by 2050 but Poland, the Czech Republic and Hungary are dragging their feet. A law would force all member states to achieve climate neutrality by 2050. Ursula von der Leyen, the new president of the European Union's executive Commission, has made combating climate change one of her top priorities. She has unveiled a "Sustainable Europe Investment Plan" which would support one trillion euros in investment over the next decade, and pledged to turn the 2050 target, something that will require a near-complete phasing-out of fossil fuels, into the "first European Climate Law."

Ex Output:
Omega-3 margarines fail to help in heart study

Ex Input:
"Anyone who follows the constant drum beat of crime news in metro Atlanta might not be surprised by a new study that puts Georgia among the most dangerous states for a very specific crime: women who are murdered by men. A Violence Policy Center report released in September shows Georgia ranks ninth among all states, with a homicide rate of 1.66 per 100,000 women in 2012, the last year data is available. The national rate is 1.16 per 100,000. ""We call on Georgia's lawmakers to make it an urgent priority to keep guns away from domestic abusers and protect women from harm,"" Kathryn Grant, co-founder of GunSense Georgia said in a statement related to the study. ""This is literally a matter of life and death."" PolitiFact Georgia wanted to know if our state really ranks that high on the list for women murdered by men. We went straight to the website for the Federal Bureau of Investigation's Supplementary Homicide Reports. That data showed Georgia had 102 homicides in 2012 19 percent more than the 84 tallied in the Violence Policy Center report. The VPC's study has a lower overall number because it takes that data and then weeds out crimes with more than one victim or perpetrator, said VPC policy analyst Marty Langley, who authored the report. An analysis of the SHR data, available only in hard copy from the FBI, confirms those numbers are accurate for incidents where one woman is killed by one man. James Alan Fox, a Northeastern University criminology professor who has studied and analyzed such data for decades, said the adjustment oversimplifies the information. Taking a more narrow slice of victims also allows for further analysis of their characteristics such as age (the victim in Georgia was 38) and race (51 were black and 30 were white in Georgia). And for homicides where the data could be found, 69 percent of victims were killed with guns and 93 percent of them were murdered by someone they knew, the study found. ""An overarching point we want to make with this study is that it's a myth that a woman's risk of homicide comes from being attacked by a stranger,"" said Kristen Rand, the group's legislative director. ""The risk of stranger homicide is really quite low."" But missing from the report is another key fact: the risk of homicide in Georgia is among the highest for any victims. It's easier to see in lists: Rank State 2012 Homicide Rate per 100,000, Females Murdered by Males 1 Alaska 2.57 2 South Carolina 2.06 3 Oklahoma 2.03 4 Louisiana 1.92 5 Mississippi 1.89 6 Nevada 1.83 7 Missouri 1.73 8 Arizona 1.70 9 Georgia 1.66 10 Tennessee 1.60 (Source: Violence Policy Center) Rank State 2012 Homicide Rate per 100,000, Overall 1 Louisiana 10.8 2 Mississippi 7.4 3 Alabama 7.1 4 Michigan 7.0 5 South Carolina 6.9 6 Missouri 6.5 7 Maryland 6.3 8 Delaware 6.2 9 Tennessee 6.0 10 (tie) Arkansas, Georgia 5.9 (Source: Bureau of Justice Statistics) Southern states such as Georgia dominate both lists, Fox said, because of factors beyond gender. Gun ownership rates are higher here. The South also has a long history of people solving personal conflicts with violence versus lawsuits, Fox said. And, he added, the region is also more diverse than much of the country, and murder rates by and against blacks are higher than those among whites. ""The fact that most of the states on (the VPC) list are in the south is not so much an issue of male-female violence,"" Fox said. ""It's about homicide, generally."" In summary, the data bears out the study's findings that rank Georgia ninth in the nation for the rate of women killed by men. One caveat is that tally counts only single victims and perpetrators. It ignores some crimes it hopes to draw attention to, such as a former partner killing a woman before committing suicide or a man killing his ex-partner and a new love interest, if there are two victims. More importantly, the tally also fails to acknowledge Georgia's dismal rank for the risk of homicide overall, and the other factors that contribute to it. The numbers are right, but it's also that there is more to the story."

Ex Output:
Georgia ranks No. 9 in the rate of women murdered by men.

Ex Input:
The implant operation was performed on Wednesday at the Georges Pompidou European Hospital in Paris, the biomedical firm said in a statement. It said that the male patient was awake and talking and he was being monitored in the intensive care unit. "We are delighted with this first implant, although it is premature to draw conclusions given that a single implant has been performed and that we are in the early postoperative phase", said Carmat's CEO, Marcello Conviti. Heart-assistance devices have been used for decades as a temporary solution for patients awaiting transplants, but Carmat's bioprosthetic product is designed to replace the real heart over the long run, mimicking nature's work using biological materials and sensors. It is aimed at helping the thousands of patients who die each year while awaiting a donor, and reducing the side-effects associated with transplants. "It's about giving patients a normal social life with the least dependence on medication as possible," Alain Carpentier, surgeon and Carmat co-founder, told France 2 television. Carmat estimates around 100,000 patients in the United States and Europe could benefit from its artificial heart, a market worth more than 16 billion euros ($22 billion). "We already had devices of this type but they had a relatively low autonomy. This heart will allow for more movement and less clotting. The study that is starting is being very closely watched in the medical field," Patrick Nataf, head of heart surgery at Paris Bichat hospital, told BFM TV. France's Health Minister was quick to tout the operation as a sign of the country's edge in the field of healthcare. "This news brings great pride to France," Marisol Touraine told BFM TV. "It shows we are pioneers in healthcare, that we can invent, that we can carry an innovation that will also bring great hope to plenty of people." Among Carmat's competitors for artificial heart implants are privately-held SynCardia Systems and Abiomed, both of the United States. "We're very happy for them and we wish them the best in their pursuit," said a spokesman for SynCardia, whose artificial heart is the only one approved both in the United States and the European Union and has been implanted over 1,200 times. The longest a patient has lived with SynCardia's heart is just under four years. In September, Carmat got the green light from French authorities to test the first human implants of the device on four patients in three hospitals. Earlier this year, it won approval to proceed with human implants in Belgium, Poland, Slovenia and Saudi Arabia. The Paris patient is the first worldwide to be implanted with the device, Carmat said. The patients selected for the trials suffer from terminal heart failure and the success of the device will be judged on whether they survive with the implant for at least a month. Conviti told Reuters last month Carmat hoped to finish human trials of the heart by the end of next year and to obtain approval to market them in the EU by early 2015. The Carmat device, developed by a team of engineers from Airbus parent company EADS, weighs about 900g (around 2 lb)- nearly three times more than an average healthy human heart. It is expected to cost 140,000 to 180,000 euros in Europe. It mimics heart muscle contractions and contains sensors that adapt the blood flow to the patient's moves. It is powered by external, wearable lithium-ion batteries. Inside the heart, surfaces that come into contact with human blood are made partly from bovine tissue instead of synthetic materials such as plastic that can cause blood clots. Patients that will be implanted with Carmat's devices are more likely to be men. Heart failure affects more men than women and the sheer size of the artificial heart means it can fit in 86 percent of men but only around 20 percent of women. But Carmat says it could easily manufacture a smaller version to fit the smaller bodies of women as well as patients in India and China. Carmat's shares have risen five-fold since floating on the Paris stock market in 2010, giving the company a market capitalization of about 436 million euros. ($1 = 0.7315 euros)

Ex Output:
France's Carmat implants its first artificial heart in human.